» Articles » PMID: 21876039

Human Natural Regulatory T Cell Development, Suppressive Function, and Postthymic Maturation in a Humanized Mouse Model

Overview
Journal J Immunol
Date 2011 Aug 31
PMID 21876039
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

CD4(+) regulatory T cells (Tregs) control adaptive immune responses and promote self-tolerance. Various humanized mouse models have been developed in efforts to reproduce and study a human immune system. However, in models that require T cell differentiation in the recipient murine thymus, only low numbers of T cells populate the peripheral immune systems. T cells are positively selected by mouse MHC and therefore do not function well in an HLA-restricted manner. In contrast, cotransplantation of human fetal thymus/liver and i.v. injection of CD34(+) cells from the same donor achieves multilineage human lymphohematopoietic reconstitution, including dendritic cells and formation of secondary lymphoid organs, in NOD/SCID mice. Strong Ag-specific immune responses and homeostatic expansion of human T cells that are dependent on peripheral human APCs occur. We now demonstrate that FOXP3(+)Helios(+) "natural" Tregs develop normally in human fetal thymic grafts and are present in peripheral blood, spleen, and lymph nodes of these humanized mice. Humanized mice exhibit normal reversal of CD45 isoform expression in association with thymic egress, postthymic "naive" to "activated" phenotypic conversion, and suppressive function. These studies demonstrate the utility of this humanized mouse model for the study of human Treg ontogeny, immunobiology and therapy.

Citing Articles

Immune Checkpoint Molecules as Biomarkers of Bone Infection and Clinical Outcome.

Saito M, McDonald K, Grier A, Grier A, Meghwani H, Rangel-Moreno J bioRxiv. 2025; .

PMID: 39803468 PMC: 11722373. DOI: 10.1101/2024.12.30.630837.


Origin, phenotype and autoimmune potential of T cells in human immune system mice receiving neonatal human thymus tissue.

Talaie T, Wang H, Kuo W, Danzl N, Gulsen M, Wolabaugh A Front Immunol. 2023; 14:1159341.

PMID: 37251390 PMC: 10213218. DOI: 10.3389/fimmu.2023.1159341.


Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.

Kaur K, Jewett A Cancers (Basel). 2023; 15(1).

PMID: 36612108 PMC: 9817973. DOI: 10.3390/cancers15010112.


Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice.

Bruss C, Kellner K, Ortmann O, Seitz S, Brockhoff G, Hutchinson J Cancers (Basel). 2022; 14(9).

PMID: 35565343 PMC: 9103756. DOI: 10.3390/cancers14092214.


Modeling human T1D-associated autoimmune processes.

Khosravi-Maharlooei M, Madley R, Borsotti C, Ferreira L, Sharp R, Brehm M Mol Metab. 2021; 56:101417.

PMID: 34902607 PMC: 8739876. DOI: 10.1016/j.molmet.2021.101417.


References
1.
Onoe T, Kalscheuer H, Chittenden M, Zhao G, Yang Y, Sykes M . Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs. J Immunol. 2010; 184(12):6756-65. PMC: 3086709. DOI: 10.4049/jimmunol.0901711. View

2.
Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y . Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004; 104(10):3249-56. DOI: 10.1182/blood-2004-01-0365. View

3.
Wagar E, Cromwell M, Shultz L, Woda B, Sullivan J, Hesselton R . Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol. 2000; 165(1):518-27. DOI: 10.4049/jimmunol.165.1.518. View

4.
Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A . Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006; 203(7):1693-700. PMC: 2118333. DOI: 10.1084/jem.20060468. View

5.
Tang Q, Henriksen K, Bi M, Finger E, Szot G, Ye J . In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med. 2004; 199(11):1455-65. PMC: 2211775. DOI: 10.1084/jem.20040139. View